Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Surmodics, Inc.
< Previous
1
2
Next >
Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results
July 31, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
June 10, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
May 29, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
May 01, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
April 19, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Participate in Upcoming Investor Conferences in March and April
February 27, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
February 01, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
January 22, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Host Virtual Annual Meeting of Shareholders
January 16, 2024
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
November 16, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
November 16, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28
November 14, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance
November 08, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15
November 07, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium
November 07, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications
October 31, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8
October 10, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Participate in Upcoming Investor Conferences in August
August 09, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
August 02, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2
July 12, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon
June 20, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System
June 14, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Participate in the Jefferies Healthcare Conference on June 8
May 25, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
April 26, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System
April 20, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26
April 19, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery
April 19, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20
April 11, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
March 28, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
Surmodics to Participate in Upcoming Investor Conferences in March
March 08, 2023
From
Surmodics, Inc.
Via
Business Wire
Tickers
SRDX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.